Yuichi Inoue Selected Research

Pramipexole (Mirapex)

1/2018	Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017)§.
1/2017	Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study.
9/2013	Reliability, validity, and responsiveness of the Japanese version of International Restless Legs Syndrome Study Group rating scale for restless legs syndrome in a clinical trial setting.
2/2013	Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder.
1/2012	Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder.
1/2011	Efficacy, safety and dose-response of pramipexole in Japanese patients with primary restless legs syndrome: randomized trial.
7/2010	Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
1/2010	Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichi Inoue Research Topics

Disease

23	Narcolepsy 04/2022 - 03/2002
22	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2022 - 03/2012
21	Schizophrenia (Dementia Praecox) 11/2021 - 01/2011
20	Neoplasms (Cancer) 10/2010 - 09/2002
19	Restless Legs Syndrome (Restless Legs) 01/2021 - 04/2008
18	Obstructive Sleep Apnea 01/2022 - 06/2002
14	Disorders of Excessive Somnolence (Hypersomnia) 01/2022 - 09/2003
13	Cataplexy 12/2018 - 03/2002
10	Idiopathic Hypersomnia 04/2022 - 03/2002
9	REM Sleep Behavior Disorder 01/2019 - 01/2009
8	Sleepiness 12/2021 - 05/2006
8	Sleep Wake Disorders 01/2021 - 12/2008
8	Pseudohypoaldosteronism 12/2018 - 08/2012
6	Apnea 01/2022 - 09/2003
5	Somnambulism (Sleepwalking) 04/2020 - 10/2011
5	Lung Neoplasms (Lung Cancer) 08/2010 - 02/2006
4	Feeding and Eating Disorders (Eating Disorder) 01/2021 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2020 - 12/2004
4	Cognitive Dysfunction 10/2018 - 05/2012
4	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 05/2018 - 10/2004
4	Dyskinesias (Dyskinesia) 01/2017 - 03/2005
4	Dementia (Dementias) 02/2014 - 12/2006
3	Obesity 01/2022 - 01/2008
3	Hypertension (High Blood Pressure) 08/2021 - 08/2014
3	Snoring 08/2021 - 09/2003
3	Headache (Headaches) 01/2021 - 12/2015
3	Chronic Kidney Failure (Chronic Renal Failure) 11/2019 - 05/2009
3	Pneumonia (Pneumonitis) 11/2019 - 07/2013
3	Synucleinopathies 01/2017 - 05/2012
3	Psychomotor Agitation (Akathisia) 01/2017 - 01/2014
3	Alzheimer Disease (Alzheimer's Disease) 02/2014 - 12/2006
3	Fever (Fevers) 07/2013 - 01/2008
3	Neoplasm Metastasis (Metastasis) 06/2011 - 03/2006
3	Parkinson Disease (Parkinson's Disease) 01/2011 - 12/2006
3	Pneumothorax 03/2009 - 03/2007
3	Esophageal and Gastric Varices (Esophageal Varices) 04/2006 - 08/2004
2	Sleep Apnea Syndromes (Sleep Apnea) 01/2022 - 09/2003
2	Fatigue 12/2021 - 12/2015
2	Night Eating Syndrome 01/2021 - 01/2016
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021 - 01/2021
2	Healthcare-Associated Pneumonia 11/2019 - 02/2009
2	Chronic Obstructive Pulmonary Disease (COPD) 09/2019 - 05/2009
2	Chronic Disease (Chronic Diseases) 01/2017 - 01/2017
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2017 - 10/2014
2	Amnesia (Dissociative Amnesia) 01/2016 - 12/2015
2	Mental Disorders (Mental Disorder) 12/2015 - 07/2003
2	Communicable Diseases (Infectious Diseases) 01/2015 - 10/2010

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2017 - 04/2008
13	Hypnotics and Sedatives (Sedatives)IBA 12/2021 - 12/2013
12	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 03/2005
8	OrexinsIBA 04/2022 - 03/2002
8	Pramipexole (Mirapex)FDA LinkGeneric 01/2018 - 01/2010
8	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2017 - 03/2005
7	BenzodiazepinesIBA 01/2021 - 01/2014
7	Aripiprazole (Abilify)FDA Link 01/2020 - 01/2011
6	Paliperidone Palmitate FDA Link 12/2018 - 02/2013
6	Lysine (L-Lysine)FDA Link 04/2017 - 10/2014
6	Phosphotransferases (Kinase)IBA 04/2017 - 10/2014
5	MelatoninIBA 01/2022 - 10/2012
5	Indicators and Reagents (Reagents)IBA 08/2021 - 07/2007
5	Dopamine Agonists (Dopamine Agonist)IBA 11/2019 - 01/2012
5	rotigotine FDA Link 11/2019 - 01/2013
5	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2007
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2006 - 02/2004
4	lemborexantIBA 12/2022 - 01/2020
4	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022 - 01/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 09/2019 - 08/2006
4	suvorexantIBA 10/2018 - 08/2017
4	HLA-DRB1 Chains (HLA DRB1)IBA 10/2015 - 05/2006
3	Orexin Receptor AntagonistsIBA 12/2022 - 01/2020
3	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2021 - 06/2013
3	Eszopiclone (Lunesta)FDA Link 01/2021 - 12/2012
3	GABA-A Receptors (GABA(A) Receptor)IBA 01/2021 - 01/2014
3	Modafinil (Provigil)FDA Link 01/2021 - 08/2013
3	1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA 01/2021 - 03/2012
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018 - 02/2015
3	3-Iodobenzylguanidine (Iobenguane)IBA 01/2011 - 05/2009
2	brexpiprazoleIBA 11/2021 - 01/2021
2	asenapine FDA Link 11/2021 - 01/2021
2	Immunoglobulin E (IgE)IBA 06/2021 - 04/2019
2	Dihydrotachysterol (AT 10)IBA 06/2021 - 07/2006
2	Carboplatin (JM8)FDA LinkGeneric 03/2020 - 12/2004
2	QuinolonesIBA 11/2019 - 09/2019
2	Cullin Proteins (Cullins)IBA 12/2018 - 10/2015
2	LigandsIBA 01/2018 - 07/2013
2	Dopamine Agents (Dopaminergic Agents)IBA 01/2018 - 05/2012
2	Antidepressive Agents (Antidepressants)IBA 10/2017 - 05/2009
2	Clonazepam (Rivotril)FDA LinkGeneric 01/2017 - 07/2003
2	Diazepam (Valium)FDA LinkGeneric 01/2016 - 12/2015

Therapy/Procedure

25	Therapeutics 01/2022 - 06/2002
13	Radiofrequency Ablation 06/2011 - 12/2002
12	Continuous Positive Airway Pressure 01/2022 - 08/2008
7	Aftercare (After-Treatment) 01/2021 - 09/2002
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
5	Radiotherapy 03/2020 - 10/2004
5	Injections 01/2019 - 08/2016
4	Oral Administration 06/2021 - 10/2012
3	Drug Tapering 01/2021 - 01/2016
2	Mandibular Advancement 08/2021 - 12/2007
2	Length of Stay 04/2018 - 06/2016